Related Experiment Videos
Veterinary drugs: disposition, biotransformation and risk evaluation
J Fink-Gremmels1, A S van Miert
1Department of Veterinary Basic Sciences, Utrecht University, The Netherlands.
The Analyst
|December 1, 1994
Summary
Veterinary drug approval requires rigorous evaluation, but factors like animal physiology and molecular toxicology introduce unpredictability in residue safety assessments. Emerging concerns include antimicrobial residues impacting human gut microflora, necessitating refined risk assessment methodologies.
Area of Science:
- Veterinary Pharmacology and Toxicology
- Food Safety
- Regulatory Science
Background:
- Veterinary drugs require licensing, involving evaluation of quality, efficacy, and safety by authorities.
- Despite harmonized regulations, residue formation and safety assessment face unpredictability due to physiological and pathological factors.
- Advancements in molecular toxicology and understanding of drug-organism interactions are evolving risk assessment.
Purpose of the Study:
- To discuss factors influencing veterinary drug residue formation and safety.
- To examine the impact of physiological and pathological conditions on drug disposition and metabolite formation.
- To explore the evolving methodologies of toxicological risk assessment in light of new scientific understanding and regulatory frameworks.
Main Methods:
- Review of existing legal frameworks for veterinary drug approval in the European Union.
- Analysis of factors influencing drug disposition, residue formation, and metabolite profiles in target animal species.
- Discussion of toxicological principles, including molecular toxicology and risk assessment for MRL establishment.
- Consideration of non-toxicological endpoints, such as antimicrobial residue effects on human gut microbiota.
Main Results:
- Physiological (age, sex, diet) and pathological conditions significantly influence drug disposition and residue formation.
- Molecular toxicology provides deeper insights but also highlights incomplete understanding of toxic compound interactions.
- Maximum Residue Limit (MRL) values are based on toxicological assessments and recognized principles.
- Potential risks of antimicrobial residues on human gastrointestinal microflora are gaining attention.
Conclusions:
- Current veterinary drug safety assessment, while regulated, faces inherent unpredictability.
- Evolving toxicological knowledge and new concerns like antimicrobial effects necessitate adaptive risk assessment strategies.
- The European Union's legal framework guides but must accommodate scientific advancements in evaluating veterinary drug safety.